Taking into consideration that both HSF1 and HSP90 are ones of the factors defining tumor growth and tumor resistance to therapeutics, such knowledge is crucial for a rational development that CDK5RAP3 may be examined as a potential target for anticancer therapy. This evidence concerns the gene HSF1 and neoplasm.